L’Oréal Halts US Sales of Acne Treatment Amid Benzene Concerns
L’Oréal is recalling all lots of its Effaclar Duo acne cream in the US over potential benzene contamination. The post L’Oréal Halts US Sales of Acne Treatment Amid Benzene Concerns appeared first on Global Cosmetics News.
THE WHAT? L’Oréal is recalling all lots of its Effaclar Duo acne cream in the US over potential benzene contamination. This follows a year-long alert from an independent lab that flagged benzene in several benzoyl peroxide-based products.
THE DETAILS Effaclar Duo is marketed under L’Oréal’s La Roche-Posay brand and contains benzoyl peroxide, an ingredient known to help clear acne by killing bacteria. Tests revealed trace amounts of benzene in one lot of Effaclar Duo, prompting L’Oréal, in consultation with the FDA, to withdraw the current formula from the market. An updated formulation, in development since 2024, is expected to replace the recalled product soon.
THE WHY? Consumers and regulators have become increasingly vigilant about benzene exposure in personal care items. Valisure, the independent lab at the center of these findings, has detected the carcinogen in sunscreens, antiperspirants, dry shampoos, and hand sanitizers over the last four years—contributing to several high-profile product recalls industry-wide.
The post L’Oréal Halts US Sales of Acne Treatment Amid Benzene Concerns appeared first on Global Cosmetics News.
